Covered recipient · General Payments record
THOMAS C CHAPMAN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$4,616.84
- Reported across 303 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $633.55 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $239.45 | 3 |
| ABBVIE INC. | $230.04 | 21 |
| Nevro Corp. | $29.71 | 1 |
| Gilead Sciences, Inc. | $28.52 | 2 |
| Corcept Therapeutics | $21.15 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $19.25 | 1 |
| Phathom Pharmaceuticals, Inc. | $15.98 | 1 |
| GlaxoSmithKline, LLC. | $15.43 | 1 |
| Daiichi Sankyo Inc. | $14.01 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $13.84 | 1 |
| Organon LLC | $6.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.87 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444692 | CMS |
| ABBVIE INC. | $5.28 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444694 | CMS |
| ABBVIE INC. | $4.05 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444696 | CMS |
| ABBVIE INC. | $7.10 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444698 | CMS |
| ABBVIE INC. | $6.46 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444700 | CMS |
| ABBVIE INC. | $118.89 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444702 | CMS |
| ABBVIE INC. | $3.68 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444704 | CMS |
| ABBVIE INC. | $17.98 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444706 | CMS |
| ABBVIE INC. | $5.46 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444708 | CMS |
| ABBVIE INC. | $6.29 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444710 | CMS |
| ABBVIE INC. | $5.15 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444712 | CMS |
| ABBVIE INC. | $9.55 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444714 | CMS |
| ABBVIE INC. | $3.09 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444716 | CMS |
| ABBVIE INC. | $8.09 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444718 | CMS |
| ABBVIE INC. | $3.10 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444720 | CMS |
| ABBVIE INC. | $2.73 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444722 | CMS |
| ABBVIE INC. | $6.08 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444724 | CMS |
| ABBVIE INC. | $1.91 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444726 | CMS |
| ABBVIE INC. | $3.30 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444728 | CMS |
| ABBVIE INC. | $2.45 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444730 | CMS |
| ABBVIE INC. | $1.53 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444732 | CMS |
| AstraZeneca Pharmaceuticals LP | $122.46 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105502726 | CMS |
| AstraZeneca Pharmaceuticals LP | $103.32 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104280087 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.67 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105519765 | CMS |
| Boston Scientific Corporation | $13.84 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092573917 | CMS |
| Corcept Therapeutics | $21.15 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117790108 | CMS |
| Daiichi Sankyo Inc. | $14.01 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089407744 | CMS |
| Gilead Sciences, Inc. | $15.34 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133638704 | CMS |
| Gilead Sciences, Inc. | $13.18 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133638706 | CMS |
| GlaxoSmithKline, LLC. | $15.43 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116674927 | CMS |
| Nevro Corp. | $29.71 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130749598 | CMS |
| Organon Llc | $6.17 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136200809 | CMS |
| Phathom Pharmaceuticals, Inc. | $15.98 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151048082 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $19.25 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105903567 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.